About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
PEER COMPARISON
Peer
Comparison
Astrazeneca Pharma India Ltd.
Peer Companies
Price(Rs)
Chg(Rs)
Chg(%)
EPS(Rs.)
TTM P/E
Volume(000's)
1Year Return(%)
Divinded Yield
Book Value
Sanofi Cons. Health
4599
137
3.07
94.61
47.51
316
-5.9
1.22
118.26
Procter&Gamble Healt
5715
82.1
1.46
184.83
30.76
72
4.93
2.22
320.52
Neuland Laboratories
15023.05
60.2
0.4
186.51
80.17
1661
11.73
0.08
1182.3
Everest Organics
503.45
45.2
9.86
6.81
72.69
6315
70.52
0
71
Haleos Labs
1268.95
44.8
3.66
62.97
20.15
2
5.57
0.12
652.19
Onesource Specialty
1764.6
22.65
1.3
14.29
123.8
13973
0
516.29
Kwality Pharma
1120
18.55
1.68
47.31
22.47
15291
27.58
0
255.44
Jenburkt Pharma
1089.95
15.25
1.42
74.77
14.58
452
-9.25
1.65
389.23
FDC
422.2
14.75
3.62
14.52
29.59
4137
-16.16
1.24
140.48
CORONA Remedies
1378
13.4
0.98
24.37
56.14
15641
0.54
99.04
Glaxosmithkline Phar
2475
10.1
0.41
55.99
44.21
3433
10.4
2.18
115.94
Senores Pharmaceutic
822.95
9.15
1.12
2.65
312.08
6952
0
153.74
Trident Lifeline
290
9.15
3.26
10.94
25.46
12000
6.23
0
57.14
NGL Fine-Chem
1299.5
8.05
0.62
25.58
50.88
81
-29.19
0.13
452.6
Hester Biosciences
1591
7.7
0.49
34.23
46.25
47
-33.6
0.44
398.6
Concord Biotech
1346.9
7.1
0.53
30.73
43.39
1151
-38.4
0.8
173.27
SMS Pharmaceuticals
312.6
6.6
2.16
8.66
35.81
19246
35.18
0.13
74.13
Ajanta Pharma
2686.4
5.6
0.21
76.07
35.34
1585
-3.9
1.04
289.84
Gufic Biosciences
339
5.15
1.54
5.42
62.74
2437
-24.92
0.03
59.96
Acutaas Chemicals
1656.8
5.15
0.31
27.57
59.68
18227
46.35
0.05
160.19
Page
1
of
10
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.